Skip to content
drillr.ai

DNA

Ginkgo Bioworks Holdings, Inc.

NYSE · USHealthcareBiotechnology
$7.55-4.55%

Price as of Jul 20, 2026

DNA news

Ginkgo Bioworks Holdings, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

    Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery PR Newswire BOSTON, May 26, 2026 New co-developed product delivers a complete Tier 1 ADME panel coupled with best-in-class AI-driven human pharmacokinetic (PK) projection and integrated compound management —enabling scientists to make lead-optimization-quality decisions starting in hit identification BOSTON, May 26, 2026

    PR Newswire ·

  2. Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

    Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation PR Newswire BOSTON, April 30, 2026 Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026 BOSTON, April 30, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, beginning at 4:30 p.m. ET. (https://mma.prne

    PR Newswire ·

  3. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    For best results when printing this announcement, please click on link below: https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nPn4RtdMka&default-theme=true Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business PR Newswire BOSTON, Feb. 26, 2026 Ginkgo provides an update on its fourth quarter financial results BOSTON, Feb. 26, 2026 /PRNew

    PR Newswire ·